id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2025-N-5997-0001,FDA,FDA-2025-N-5997,Biosimilar User Fee Act; Stakeholder Consultation Meetings on Biosimilar User Fee Act Reauthorization; Request for Notification of Stakeholder Intention To Participate,Notice,General Notice,2025-12-12T05:00:00Z,2025,12,2025-12-12T05:00:00Z,,2025-12-13T00:47:14Z,2025-22619,0,0,09000064b90c85ad